MG

Michael Gladstone

Partner at Atlas Venture

Greater Boston

Overview

Work Experience

AV

Atlas Venture

  • Partner

    2020 - Current

  • Principal

    2015

AV

Atlas Venture

  • Associate

    2012 - 2014

LC

L.E.K. Consulting

  • Senior Associate Consultant

    2009 - 2012

EP

Eutropics Pharmaceuticals

  • MLSC Fellow

    2009 - 2009

Education

Investments

Pheon Therapeutics

Series A

Total Funding: $190M

Diagonal Therapeutics

Series A

Total Funding: $130M

SAPI

Undisclosed

Total Funding: $10M

Versanis Bio

Series A

Total Funding: $70M

Relevant Websites